Financial Metrics Unveiled: ATAI Life Sciences N.V. (ATAI)’s Key Ratios in the Spotlight

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of ATAI Life Sciences N.V. (NASDAQ: ATAI) closed at $1.22 in the last session, down -2.40% from day before closing price of $1.25. In other words, the price has decreased by -$2.40 from its previous closing price. On the day, 0.81 million shares were traded. ATAI stock price reached its highest trading level at $1.285 during the session, while it also had its lowest trading level at $1.2.

Ratios:

We take a closer look at ATAI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.68 and its Current Ratio is at 6.68. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.

On November 01, 2022, Loop Capital started tracking the stock assigning a Buy rating and target price of $18.

On November 30, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $25.Maxim Group initiated its Buy rating on November 30, 2021, with a $25 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 16 ’24 when Brand Florian sold 151,303 shares for $1.92 per share. The transaction valued at 290,502 led to the insider holds 328,697 shares of the business.

Johnson Anne Nagengast sold 27,410 shares of ATAI for $50,708 on Apr 02 ’24. The Chief Financial Officer now owns 73,590 shares after completing the transaction at $1.85 per share. On Apr 02 ’24, another insider, Rao Srinivas, who serves as the insider of the company, sold 61,640 shares for $1.85 each. As a result, the insider received 114,034 and left with 113,360 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATAI now has a Market Capitalization of 204714800 and an Enterprise Value of 129901992. For the stock, the TTM Price-to-Sale (P/S) ratio is 538.73 while its Price-to-Book (P/B) ratio in mrq is 1.22. Its current Enterprise Value per Revenue stands at 343.656 whereas that against EBITDA is -1.241.

Stock Price History:

Over the past 52 weeks, ATAI has reached a high of $2.85, while it has fallen to a 52-week low of $1.02. The 50-Day Moving Average of the stock is -12.37%, while the 200-Day Moving Average is calculated to be -24.88%.

Shares Statistics:

According to the various share statistics, ATAI traded on average about 848.80K shares per day over the past 3-months and 798600 shares per day over the past 10 days. A total of 166.03M shares are outstanding, with a floating share count of 116.95M. Insiders hold about 30.29% of the company’s shares, while institutions hold 7.46% stake in the company. Shares short for ATAI as of 1722384000 were 8777326 with a Short Ratio of 10.34, compared to 1719532800 on 8324709. Therefore, it implies a Short% of Shares Outstanding of 8777326 and a Short% of Float of 6.87.

Most Popular